IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
36.20
+0.19 (0.53%)
Jan 22, 2026, 4:00 PM EST - Market closed
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $3.17 billion as of January 23, 2026. Its market cap has increased by 41.22% in one year.
Market Cap
3.17B
Enterprise Value
2.06B
1-Year Change
41.22%
Ranking
Category
Stock Price
$36.20
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $3.17B, an increase of 1,372.17%. That is a compound annual growth rate of 49.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.16B | 4.17% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liquidia | 3.46B |
| Centessa Pharmaceuticals | 3.38B |
| Alumis | 3.28B |
| Vera Therapeutics | 3.23B |
| Xenon Pharmaceuticals | 3.22B |
| Arcutis Biotherapeutics | 3.18B |
| Viridian Therapeutics | 3.10B |
| Beam Therapeutics | 3.05B |